BLR Bio
BREAKTHROUGH THERAPIES
Focused on Fibro-Inflammatory Diseases
A new approach to orphan, rare, and common conditions
Who We Are
Fibrosis Therapy
Fibrosis Therapy
BLR Bio is a privately held biotechnology company on the leading edge of fibro-inflammatory therapy development and a leader in developing therapeutics targeting the myofibroblast - a novel approach to address a broad spectrum of Fibrotic Diseases and Cancer
Fibrosis Therapy
Fibrosis Therapy
Fibrosis Therapy
Our fibrosis therapies restore equilibrium to the areas of the body where inflammation and fibrosis persist.
Cancer Therapy
Fibrosis Therapy
Cancer Therapy
Our cancer therapies restore antitumor immunity and suppress cancer cell proliferation and spread.